Class Action

Sanmedica’s Sero Vital-hgh

Class Action

Sanmedica’s Sero Vital-hgh

In Oct 2016, a class-action lawsuit was filed against Sanmedica International for allegedly falsely advertising that Sero Vital-hgh provides anti-aging benefits. Specifically, the complaint alleges that the company markets the pill as, among other things, having the ability to “turn back time” in the human aging process and increase Human Growth Hormone (HGH) levels in the body by 682% when, in reality, such claims are false. (Martin et al v. Sanmedica International, LLC and Does 1-10, Case No. 16-cv-7794, C. D. CA.)

For more information about other class-action lawsuits regarding anti-aging products and TINA.org’s coverage of them, click here.


Class-Action Tracker

SeroVital-hgh

Class Action

SeroVital-hgh

Allegations: Falsely marketing that supplements increase human growth hormone (HGH) levels by 682%, make users look decades younger, and provide various anti-aging benefits

SeroVital

Class Action

SeroVital

April 2017: The Ninth Circuit Court of Appeals affirmed the district court’s decision to dismiss this lawsuit. March 2015: The plaintiffs appealed the district court’s decision to dismiss the lawsuit.…


The Latest

Filters

H&R Block

Ad Alert

H&R Block

FTC alleges company pressures consumers into overpaying for its tax filing software.


Show More